LifeSpeak to acquire digital fitness platform Wellbeats for up to $117.9 million CAD
Wellbeats would mark LifeSpeak’s largest acquisition to date.
Wellbeats would mark LifeSpeak’s largest acquisition to date.
Perturba fuses AI-drug design and biological science.
Plus: Remote patient monitoring is raking in venture funding.
PerkinElmer and Ipsen purchased two of Desjardins’ previous companies.
The fund has invested in Okadoc, Exact Imaging, eSight, and MolecuLight.
Plus: What stopped The Canadian Shield from supplying the PPE and tests Canada needs?
Venture capital firms Lux Capital and Leaps by Bayer led Gandeeva’s round.
PointClickCare claims the acquisition creates access to over 150 million people.
The funding will be used to expand the number of Optina’s clinical study sites.
Felix Health, CognisantMD, and Align Technology are all hiring.
China, middle-men, and government bureaucracy.
Plus: Zymeworks stock hits three-year low.
BenchSci says its tech is used by 16 of the top 20 pharmaceutical companies.
Plus: Talkspace faces class action alleging it misled investors ahead of SPAC deal.
The partnership gives Amplitude access to Alberta’s sizeable AI sector.